The Medicines Patent Pool is improving access to essential medication where it’s most needed, but does it make economic sense?
The Conversation Africa
byBruno Versaevel, Professor of industrial economics, EM Lyon Business School, Etienne Billette de Villemeur, Professor, Université de Lille, Vianney Dequiedt, Professor of Economics, Université Clermont Auvergne (UCA)
Monday, August 17, 2026 at 01:02 PM
Three economists explore the viability of a UN-backed one-stop licensing ‘hub’ for making essential, often life-saving biotherapeutics and vaccines both affordable and more widely available.
A new UN-backed initiative is enabling qualified generic manufacturers to develop, produce and supply vital medicines such as antivirals independently. By reducing the cost of essential medicines, po… [+7332 chars]
Language
eng
Source
The Conversation Africa
Category
business
Added
11d ago
